Virtu Financial’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Virtu Financial’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9	Closed	-$23K	–	2248
2022 Q4	$23K	Buy	+9	New	+$31.4K	﹤0.01%	1243
2022 Q1	–	Sell	-9	Closed	-$55K	–	2176
2021 Q4	$55K	Sell	9 -32	-78%	-$246K	0.01%	1320
2021 Q3	$378K	Buy	41 +19	+86%	+$163K	0.03%	602
2021 Q2	$227K	Buy	+22	New	+$362K	0.02%	909
2021 Q1	–	Sell	-22	Closed	-$134K	–	2129
2020 Q4	$134K	Buy	+22	New	+$86.3K	0.01%	980
2020 Q3	–	Sell	-25	Closed	-$97K	–	1627
2020 Q2	$97K	Buy	+25	New	+$83K	0.01%	891
2019 Q4	–	Sell	-19	Closed	-$68K	–	1940
2019 Q3	$68K	Buy	+19	New	+$114K	0.01%	1150
2019 Q1	–	Hold	0	–	-$4K	–	1949
2018 Q4	–	Hold	0	–	–	–	1489
2018 Q3	–	Hold	0	–	–	–	1427
2018 Q2	–	Hold	0	–	–	–	1885
2018 Q1	–	Hold	0	–	–	–	1872
2017 Q4	–	Hold	0	–	–	–	2215

Other funds holding SEEL

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's SEEL Position: Q1 2023 in Review

Virtu Financial sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2023, closing a stake of 9 shares — an estimated $23K sold.

Virtu Financial first reported a position in SEEL in Q3 2019 and held it in 7 quarters. The position peaked at $378K in Q3 2021. 60 funds tracked by Wall St. Rank hold SEEL as of Q1 2023.

Virtu Financial reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 9 Seelos Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $23K.
Virtu Financial first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
Virtu Financial's Seelos Therapeutics, Inc. Common Stock position peaked at $378K in Q3 2021.
60 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.